Clinical Investigation of the Safety and Effectiveness of the ABV-1701 Ocular Endotamponade (OE)

计划入组 40 人 · 首次发布于 2022 年 6 月 10 日

A Trial of SHR-1701 in Subjects With Advanced Solid Tumors

计划入组 41 人 · 首次发布于 2020 年 3 月 27 日

A First-in-human Study of Multiple Doses of BB-1701 in Subjects With Locally Advanced/Metastatic HER2 Expressing Solid Tumors

计划入组 117 人 · 首次发布于 2020 年 2 月 5 日

ABV-1703

ABV-1601

ABV-1501

701 RESEARCH INC.

Japan

DBV Technologies

France

浙江章光101有限公司

ABVC BioPharma Reports $1.27 Million Q3 Licensing Revenue as CNS Pipeline Advances Toward Phase III

ABVC BioPharma Secures Japanese Patent for Botanical Depression Treatment Through 2040

ABVC BioPharma Projects $19 Million Revenue from Global Licensing Deals and Strategic CDMO Acquisition